Related Experiment Videos
Progesterone receptor gene polymorphism and risk for breast and ovarian cancer
British Journal of Cancer
|July 31, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic gene expression signature for high-grade serous ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis.
British journal of cancer·2009
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.
British journal of cancer·2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
British journal of cancer·2009
Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.
British journal of cancer·2026
Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.
British journal of cancer·2026
Radiomics as a spatial context for treatment decision-making in head and neck cancer.
British journal of cancer·2026
Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).
Iranian biomedical journal·2026
Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.
Lung cancer (Amsterdam, Netherlands)·2026